FDA Approved: LOTEPREDNOL ETABONATE AND TOBRAMYCIN — Supplemental Application (Bausch & Lomb Americas Inc.)

View source ↗

Summary

FDA approved a supplemental application for the Loteprednol etabonate and tobramycin ophthalmic product from Bausch & Lomb Americas Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bacterial Conjunctivitis

Drugs mentioned

• Loteprednol etabonate and tobramycin (Loteprednol etabonate and tobramycin)

Snippet

SUPPL AP for LOTEPREDNOL ETABONATE AND TOBRAMYCIN (LOTEPREDNOL ETABONATE AND TOBRAMYCIN)